White Rock Therapeutics

UEI
X74CWG22J461
CAGE
90BQ9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

White Rock Therapeutics's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase i: ACE2 decoy as a pan-coronavirus therapeutic (covid-19) Grant · 2136508 Division of Industrial Innovation $256,000

Quick answers

What is White Rock Therapeutics's UEI?

White Rock Therapeutics's Unique Entity ID (UEI) in SAM.gov is X74CWG22J461.

What is White Rock Therapeutics's CAGE code?

White Rock Therapeutics's CAGE code is 90BQ9.

What is White Rock Therapeutics's primary NAICS code?

White Rock Therapeutics's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is White Rock Therapeutics registered in SAM.gov?

White Rock Therapeutics's SAM.gov registration expired on January 7, 2025.

What is White Rock Therapeutics's most recent federal award?

White Rock Therapeutics's most recent federal grant award is Sbir phase i: ACE2 decoy as a pan-coronavirus therapeutic (covid-19) (2136508), from Division of Industrial Innovation, on January 1, 2022.

On GovTribe

See White Rock Therapeutics's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login